News · Nutrition & Diet
The Portfolio diet tracked 10% lower death risk across 513,284 people in four cohorts
A Critical Reviews in Food Science and Nutrition analysis pooled 10 studies of the cholesterol-lowering Portfolio diet. Each step up the adherence score went with 6% less cardiovascular disease and 10% lower all-cause mortality.
- 10 observational studies and 513,284 participants, searched to September 2025.
- Disease outcomes came from 4 prospective cohorts covering 352,396 people.
- Each 1-SD rise in Portfolio Diet Score: 6% less cardiovascular disease (RR 0.94).
- Same step: 10% lower all-cause mortality (RR 0.90, 95% CI 0.86-0.95).
- Diabetes and cancer signals were qualitative only, and remain hypothesis-generating.
Most famous diets were spotted before they were designed. Somebody noticed that Cretans had good hearts, or that Okinawans lived a long time, and the research followed the population.
The Portfolio diet went the other way. It was assembled in a lab from four foods that each lower cholesterol a little, on the theory that four small effects stacked would rival a drug: plant sterols, viscous soluble fiber, soy protein and nuts, eaten together rather than one at a time. For two decades that was all it was, a cholesterol intervention with a good mechanism and no long-term outcome data.
Chan and colleagues, writing in Critical Reviews in Food Science and Nutrition, have now pooled 10 studies consisting of 513,284 participants to ask whether the people who happen to eat this way actually live longer. Each step up the adherence score went with a 10% lower risk of all-cause mortality.
What a standard deviation of diet looks like
The unit here needs unpacking, because it is not “switching to the Portfolio diet”.
Each 1-standard deviation increase in the Portfolio Diet Score was associated with a 6% lower risk of cardiovascular disease and a 10% lower risk of all-cause mortality. A standard deviation is roughly the typical spread across the population, so the comparison is between someone eating this way a bit more than average and someone eating it a bit less. It is a nudge along a scale, not a conversion.
That makes the mortality figure larger than it first appears. Ten percent for a nudge is a bigger claim than ten percent for a wholesale change, because the exposure contrast is so much smaller.
Where the numbers come from
Not all 513,284 people contributed to the headline. Data from 4 prospective cohort studies, covering 352,396 people, were pooled using random-effects models for disease outcomes; the rest of the studies informed the review without entering that calculation.
Four cohorts is a thin base for a pooled estimate, and it is the main reason to hold this result loosely. The intervals around both figures are tight, which reflects the enormous sample rather than a large number of independent findings. Tight intervals from few studies are a different thing from tight intervals from many.
Everyone in those cohorts also chose their own food. People who score high on a plant-sterol-and-soy-protein index are, on average, people who exercise, do not smoke, and can afford almonds. The authors adjust for what the original studies measured, and there is no adjusting for what they did not.
The two outcomes that did not get pooled
Qualitative synthesis suggested that higher adherence was associated with lower type 2 diabetes risk and lower odds of cancer. Qualitative synthesis is the phrase to notice: the studies were described side by side rather than combined into a number, usually because they measured things too differently to add up.
The authors are direct about what that is worth, calling those associations preliminary and hypothesis-generating. Treat them as reasons to run the next study, not as findings.
Why this diet is different from the others
Heart disease is the leading cause of death in the United States, and it is also a major cause of disability. The standard dietary advice against it is a list: limit saturated fats, foods high in sodium and added sugars, and eat plenty of fresh fruit, vegetables, and whole grains.
The Portfolio diet is narrower than that and more specific. It names four things and asks you to eat all of them, because the case for it was never that these foods are wholesome. It was that plant sterols block cholesterol absorption, viscous fiber traps bile acids, soy protein alters liver handling of cholesterol, and nuts supply unsaturated fat in place of saturated. Four different routes to the same number.
That design is why the mortality finding matters more than another observational diet result would. The mechanism was specified in advance, the cholesterol effect was demonstrated in trials first, and this analysis asks whether the downstream outcome followed. It did, in people who were never assigned to anything.
What to actually put in the trolley
Nothing here requires a new shopping habit so much as four of them at once: oats or barley most days, a handful of nuts, soy in some form, and a sterol-fortified spread if you use one.
Cholesterol is the reason. High levels of cholesterol can clog your arteries and raise your risk of coronary artery disease and heart attack, and this pattern was built to move that number without a prescription.
Two limits belong on it. Nobody has randomly assigned people to eat this way for a decade and counted deaths, so the strongest claim available is association. And a diet that lowers cholesterol is not a replacement for a drug that lowers cholesterol; for anyone already on a statin, this is a thing to do alongside, and a conversation to have before changing anything.
People also ask
What did the meta-analysis find?
Each 1-standard deviation increase in the Portfolio Diet Score (PDS) was associated with a 6% lower risk of cardiovascular disease (CVD) (RR = 0.94, 95% CI: 0.92 to 0.96) and a 10% lower risk of all-cause mortality (RR = 0.90, 95% CI: 0.86 to 0.95).
What is the Portfolio diet?
A cholesterol-lowering pattern built from four food groups eaten together: plant sterols, viscous soluble fiber such as oats and barley, soy protein, and nuts. It was designed in the early 2000s to work as a portfolio, on the logic that four modest effects combined would beat any one of them alone.
What is a Portfolio Diet Score?
A number that rates how closely someone's reported eating matches that pattern. A 1-standard-deviation increase means moving up by about as much as the typical spread across the population, not switching diets entirely.
Is this cause and effect?
No. These are observational studies, so people chose their own diets and the analysis adjusts for what the original researchers happened to measure. The authors state that higher adherence is inversely associated with risks of CVD and mortality, which is the correct wording for this design.
What about diabetes and cancer?
Weaker. Qualitative synthesis suggested that higher adherence to the Portfolio diet was associated with lower type 2 diabetes risk and lower odds of cancer, but the authors describe those associations as preliminary and hypothesis-generating. Qualitative synthesis means the studies were described rather than pooled into a number.
How does this compare to other diet patterns?
The effect sizes sit in the same range as the Mediterranean and DASH patterns in comparable cohort research. What distinguishes the Portfolio diet is that it was engineered backwards from a mechanism, cholesterol lowering, rather than observed in a population and studied afterwards.
Should someone switch to it?
Its components are uncontroversial on their own. A healthy eating plan includes eating a variety of foods, including vegetables, fruits, and whole-grain products, and eating lean meats, poultry, fish, beans, and low-fat dairy products, while limiting salt, added sugars, alcohol, and saturated fat. Anyone on cholesterol medication should treat diet as an addition rather than a substitute and raise changes with their doctor. This is general information rather than medical advice.
References
- Chan, V. W. K., Gebretsadik, G. G., Tse, M. T. H., Lai, G. Z., Leung, L. Y.-L., Glenn, A. J., Kendall, C. W. C., Kavanagh, M. E., Chiavaroli, L., Jenkins, D. J. A., Sievenpiper, J. L., Lo, K. K. H. The Portfolio diet and disease outcomes: a systematic review and meta-analysis of observational studies. Critical Reviews in Food Science and Nutrition, 2026.
- MedlinePlus. How to Prevent Heart Disease. US National Library of Medicine.
- MedlinePlus. Nutrition. US National Library of Medicine.